Analyst Activity – Credit Suisse Group Raises Its Price Target On NASDAQ:ALXN – Alexion Pharmaceuticals (NASDAQ:ALXN) to

ME Staff
-
0

Analyst Ratings For NASDAQ:ALXN – Alexion Pharmaceuticals (NASDAQ:ALXN)

Today, Credit Suisse Group raised its price target on NASDAQ:ALXN – Alexion Pharmaceuticals (NASDAQ:ALXN) to per share.

Some recent analyst ratings include

  • 4/23/2018-Raymond James Reiterated Rating of Buy.

Recent Insider Trading Activity For NASDAQ:ALXN – Alexion Pharmaceuticals (NASDAQ:ALXN)
NASDAQ:ALXN – Alexion Pharmaceuticals (NASDAQ:ALXN) has insider ownership of 4.35% and institutional ownership of 92.26%.

  • On 4/30/2018 Christopher J Coughlin, Director, bought 10,000 with an average share price of $120.79 per share and the total transaction amounting to $1,207,900.00.
  • On 2/28/2018 Heidi L Wagner, SVP, sold 698 with an average share price of $119.35 per share and the total transaction amounting to $83,306.30.
  • On 2/28/2018 Julie O’neill, EVP, sold 1,625 with an average share price of $119.83 per share and the total transaction amounting to $194,723.75.
  • On 2/8/2018 Heidi L Wagner, SVP, sold 1,774 with an average share price of $116.31 per share and the total transaction amounting to $206,333.94.
  • On 2/8/2018 John B Moriarty, EVP, sold 3,363 with an average share price of $115.70 per share and the total transaction amounting to $389,099.10.
  • On 2/8/2018 Ludwig Hantson, CEO, sold 13,245 with an average share price of $116.31 per share and the total transaction amounting to $1,540,525.95.
  • On 2/8/2018 Paul J Clancy, CFO, sold 6,079 with an average share price of $116.31 per share and the total transaction amounting to $707,048.49.

Recent Trading Activity for NASDAQ:ALXN – Alexion Pharmaceuticals (NASDAQ:ALXN)
Shares of NASDAQ:ALXN – Alexion Pharmaceuticals closed the previous trading session at 119.42 down -0.36 0.30% with 120.19999694824219 shares trading hands.